Britcher Leone, LLC
Call Today For A Free Consultation
Glen Rock, Local: 201-444-1644
Parsippany, Local: 973-898-1766
Toll Free: 877-963-3625
October is Breast Cancer Awareness Month

Vaccine Archives

An Ebola Vaccine - But for Whom?

The push to develop a vaccine against the Ebola virus is on, and vaccination is going to be an important part of controlling this contagious disease. Phase 1 trials are slated to begin soon in the United States. Even if adequate safety and immunogenicity are demonstrated in the phase 1 studies, vaccines will not be available in substantial quantity until the first quarter of 2015 at the earliest. Even if an effective vaccine can be produced, it is not likely to be 100% effective to succeed in stemming the current or future outbreaks. There are different strains and the virus continues to mutate. While I agree that an Ebola vaccine is an important of the global strategy to control the virus, I do not agree that Americans should receive an Ebola vaccine and be subjected to the risk a serious adverse event or death, unless they are traveling to an endemic area. So why are we doing these Phase 1 trials on Americans?

Japan Withdraws Recommendation for HPV Vaccine

The Japanese Health Ministry withdrew HPV Vaccination recommendations for young girls to help prevent cervical cancer because of numerous complaints of side effects. Hundreds of vaccinated girls have complained of long term pain and numbness after receiving the vaccine. While the ministry is not suspending the use fo the vaccination, it has instructed local governments to not promote its use. This withdrawal of immunization recommendation is unusual because it was used regularly by local goverments and is required by law.

Need for Influenza Vaccine Questioned

Has the need for the influenza vaccine been "overhyped", and does belief in its safety and benefit rest on shaky scientific ground? Yes, says a recent article in the British Medical Journal, which points out that the enormous growth of this market has not been because of patient demand, but rather an intense public health campaign promoting it as a virtually risk free way to save lives and illness from influenza. These assertions may not be true, and yet annual flu vaccine doses  in the United States grew from 32 million in 1990 to over 135 million today. Flu shots are administered in clinics, pharmacies and even drive through centers. But not everyone wants to have one, but the pressure to vaccinate is high and the risks are minimized if acknowledged at all. Serious and life threatening injuries can occur from an flu shot. The risk of Guillian Barre Syndrome after vaccination  is estimated at 1 to 2 cases per million people. Is the market driven by patient benefit or by the benefit to manufacturers with the government support?

Pertussis Vaccine Recommended For All Pregnant Womend

The incidence of pertussis (whooping cough) has risen dramatically in recent years reflecting the relative weak immunogenicity of the acellular vaccine compared with the prior whole-cell vaccine used prior to 1996. The vaccine is typically given as a combination known as Tdap (tetanus, diphtheria and acellular pertussis). To compensate for the reduced effectiveness of the acellular form, the Advisory Committee on Immunization Practices (ACIP) now recommends that adults and adolescents get booster shots to provide protection from infection. However, the booster has not lowered the incidence of the disease in neonates. The recommendation is supported by the American College of Obstetricians and Gynecologists (ACOG) except for women who have been previously vaccinated.

HPV Vaccine Not Popular With Parents

Although the HPV vaccine has been recommended for teenage girls to help prevent the development of cervical cancer caused by infection with high risk serotypes of the Human Papilloma Virus (HPV), about 75% of teenage girls were not current with the HPV vaccination. More than 40% of parents reported that they had no intention of having their daughters complete the HPV immunization process. Parents' reasons for not completing this immunization schedule included beliefs that it was not needed or necessary (17%), safety concerns (16%), lack of sexual activity in the children (11%) and lack of knowledge (10%). This study was conducted between 2008 and 2010 and included a review of the tetanus diphtheria and acellular pertussis (Tdap), the quadrivalent meningococcal (MCV4) and the HPV immunization. About 20% of teens were not up-to-date for the Tdap immunizations and approximately 65% were not up-to-date for the MCV4 immunizations.  

Contact Us

Britcher Leone, LLC

Glen Rock
175 Rock Road
Suite 4
Glen Rock, NJ 07452-1724

Toll Free: 866-713-1795
Toll Free: 877-600-7665
Phone: 201-345-5306
Phone: 201-444-1644
Glen Rock Law Office

Parsippany
7 Century Road
Parsippany, NJ 07054

Toll Free: 866-713-1795
Toll Free: 877-600-7665
Phone: 201-345-5306
Phone: 973-898-1766
Map & Directions